PEGylated recombinant human tumor necrosis factor alpha: Preparation and anti-tumor potency

Acta Pharmacologica Sinica

Volumn 22, Issue 6, 2001, Pages 549-555

  Li, Y P ^a   Pei, Y Y ^a   Ding, J ^a   Shen, Z M ^a   Zhang, X Y ^a   Gu, Z H ^a   Zhou, J J ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Peptides; Polyethylene glycol; Recombinant proteins; Tumor necrosis factor

Indexed keywords

MACROGOL; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SUCCINIMIDE DERIVATIVE; ANTINEOPLASTIC AGENT; MACROGOL DERIVATIVE; METHOXYPOLYETHYLENE GLYCOL SUCCINIMIDYLSUCCINATE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEGRADATION; DRUG FORMULATION; DRUG POTENCY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PROTEIN DEGRADATION; SOLID TUMOR; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG EFFECT; MALE; PATHOLOGY; PROTEIN PROCESSING; SARCOMA 180;

ANIMAL; ANTINEOPLASTIC AGENTS; MALE; MICE; POLYETHYLENE GLYCOLS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SARCOMA 180; SUCCINIMIDES; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR;

EID: 0034975622     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The inhibition of neoplastic cell proliferation with human natural tumor necrosis factor
2. Immunomodulatory and toxic effects of free and liposome-encapsulated tumor necrosis factor-α in rats
3. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo
4. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma
5. Phase I study of intratumoral application of recombinant human tumor necrosis factor
6. Chemical modification of natural human tumor necrosis factor-α with polyethylene glycol increases its anti-tumor potency
7. Intraveneous administration of polyethylene glycol-modified tumor necrosis factor-α completely regressed solid tumor in meth-A murine sarcoma model
8. Molecular design of hybrid tumor necrosis factor alpha with polyethylene glycol increases its anti-tumor potency
9. Molecular design of hybrid tumor necrosis factor-a II: The molecular size of polyethylene glycol-modified tumor necrosis factor-a affects its anti-tumor potency
10. In vivo anti-tumor efficacy of polyethylene glycol-modified tumor necrosis factor-α against tumor necrosis factor-resistant tumors
11. Molecular design of hybrid tumor necrosis factor-a III: Polyethylene glycol-modified tumor necrosis factor-a has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation
12. Molecular design of conjugated tumor necrosis factor-a synthesis and characteristics of polyvinyl pyrrolidone modified tumor necrosis factor-α
13. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein dye binding
14. An endotoxin-induced serum factor that causes necrosis of tumors
15. Physicochemical characterization of PEG-PPG conjugated human urokinase
16. Pseudomonas exotoxin A mutants. Replacement of surface exposed residues in domain II with cysteine residues that can be modified with polyethylene glycol in a site-specific manner
17. Uptake, intracellular transport, and degradation of polyethylene glycol-modified asialofetuin in hepatocytes
18. IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency
19. Relationship between surface hydrophilicity of a protein and its stability against denaturation by organic solvents
20. A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C
21. The role of interferon-alpha in the treatment of myeloproliferative disorders
22. Treatment of idiopathic CD4 T lymphocytopenia with IL-2
23. Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens
24. + cells in improved immunological function in an adenosine deaminase (ADA)-SCID patient
25. Enzymatic activity of chymotrypsin and its polyethylene glycol conjugates toward low and high molecular weight substrates
26. Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes
27. 1H-NMR spectroscopy and conformation of the conjugates
28. The structure of tumor necrosis factor-α at 2.6 Â resolution
29. Disposition characteristics of macromolecules in the perfused tissue-isolated tumor preparation
30. Enhancement of blood stasis and vascularpermeability in Meth-A tumors by administration of hyperthermia in combination with tumor necrosis factor